Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Qsam Therapeutics, Inc.

Clinical trials sponsored by Qsam Therapeutics, Inc., explained in plain language.

Can a radioactive injection target bone tumors? a Dose-Finding trial aims to find out

Disease control Stopped early

This early-stage trial is testing an experimental drug called CycloSam (153-Sm-DOTMP), a radioactive compound that delivers radiation directly to bone tumors when injected. The study aims to find the safest dose in people aged 15 to 75 with solid tumors that have spread to the bo…

Phase 1 • Sponsor: QSAM Therapeutics, Inc. • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC